• Login
    View Item 
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjects

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    A framework for the in vitro evaluation of cancer-relevant molecular characteristics and mitogenic potency of insulin analogues.

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Authors
    Baricevic, Ivona
    Jones, David R
    Roberts, Darren L
    Lutzen, A
    Lundby, A
    Worm, J
    Hansen, B
    Renehan, Andrew G
    Affiliation
    Institute of Cancer Sciences, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK
    Issue Date
    2015-05-30
    
    Metadata
    Show full item record
    Abstract
    Epidemiological and laboratory studies raised the possibility of a link between clinically prescribed insulin analogues and increased cancer risk. Accordingly, there is a regulatory mandate for cancer-related pre-clinical safety evaluation during insulin analogue development, but currently, there is no standardised framework for such in vitro evaluation. We tested human insulin; the super-mitogenic insulin, X10; and IGF-I, in four cancer cell lines with a range of IGF-IR/IR ratios (HCT 116, HT-29, COLO 205, MCF7), and related these to IGF-IR and IR expression in 17 human adenocarcinomas. All cell types were IRA isoform dominant. We determined IGF-IR/IR signalling pathway endpoints in dose- and time-varying experiments, and performed mitogenic dose-response equivalent assays to derive EC50 values, and correlated these with IGF-IR/IR ratios. We superimposed relative EC50 values onto data from the literature in a meta-analysis. The IGF-IR/IR ratios varied from < 1 to 12 in the selected cell lines; similar pattern ranges were observed in human adenocarcinomas. The three ligands demonstrated differential IR/IGF-IR and Akt phosphorylation, which correlated with cell-specific IGF-IR/IR ratios. Mitogenic profiles of X10 mimicked those for IGF-I, and correlated with IGF-IR/IR ratios. The meta-analysis, adding data from 5 additional studies, supported the hypothesis that ligand mitogenic potency, relative to human insulin, increases with increasing cell-specific IGF-IR/IR ratio. This study established a framework for the in vitro evaluation of cancer-relevant bio-assays for comparisons of insulin analogues, and specifically consolidated earlier studies that determination of the cell-specific IGF-IR/IR ratio is crucial for the interpretation of ranking relative biological activities.
    Citation
    A framework for the in vitro evaluation of cancer-relevant molecular characteristics and mitogenic potency of insulin analogues. 2015: Carcinogenesis
    Journal
    Carcinogenesis
    URI
    http://hdl.handle.net/10541/558712
    DOI
    10.1093/carcin/bgv071
    PubMed ID
    26026165
    Type
    Article
    Language
    en
    ISSN
    1460-2180
    ae974a485f413a2113503eed53cd6c53
    10.1093/carcin/bgv071
    Scopus Count
    Collections
    All Christie Publications

    entitlement

    Related articles

    • Surface-expressed insulin receptors as well as IGF-I receptors both contribute to the mitogenic effects of human insulin and its analogues.
    • Authors: Lundby A, Bolvig P, Hegelund AC, Hansen BF, Worm J, Lützen A, Billestrup N, Bonnesen C, Oleksiewicz MB
    • Issue date: 2015 Jul
    • Autocrine IGF-I/insulin receptor axis compensates for inhibition of AKT in ER-positive breast cancer cells with resistance to estrogen deprivation.
    • Authors: Fox EM, Kuba MG, Miller TW, Davies BR, Arteaga CL
    • Issue date: 2013
    • Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
    • Authors: Bartucci M, Morelli C, Mauro L, Andò S, Surmacz E
    • Issue date: 2001 Sep 15
    • Classifying the adverse mitogenic mode of action of insulin analogues using a novel mechanism-based genetically engineered human breast cancer cell panel.
    • Authors: ter Braak B, Siezen CL, Kannegieter N, Koedoot E, van de Water B, van der Laan JW
    • Issue date: 2014 Apr
    • Analysis of signaling pathways related to cell proliferation stimulated by insulin analogs in human mammary epithelial cell lines.
    • Authors: Shukla A, Grisouard J, Ehemann V, Hermani A, Enzmann H, Mayer D
    • Issue date: 2009 Jun
    DSpace software (copyright © 2002 - 2023)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.